Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with duchenne muscular dystrophy

Anesthesiology

Volumn 110, Issue 5, 2009, Pages 1016-1019

  Ihmsen, Harald ^a   Schmidt, Joachim ^a   Schwilden, Helmut ^a   Schmitt, Hubert J ^b   Muenster, Tino ^a,b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MIVACURIUM; PROPOFOL; REMIFENTANIL; ISOQUINOLINE DERIVATIVE;

ADOLESCENT; AGE DISTRIBUTION; ANESTHESIA INDUCTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; COURSE EVALUATION; DISEASE COURSE; DRUG DOSE TITRATION; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; MALE; MYOGRAPHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE; AGE; COMPARATIVE STUDY; METHODOLOGY; PATHOPHYSIOLOGY;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; HUMANS; ISOQUINOLINES; MALE; MUSCULAR DYSTROPHY, DUCHENNE; NEUROMUSCULAR BLOCKADE;

EID: 65549125429     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31819daf31     Document Type: Article

References (17)

1. Blake DJ, Kröger S: The neurobiology of duchenne muscular dystrophy: Learning lessons from muscle? Trends Neurosci 2000; 23:92-9
2. Emery AE: Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord 1991; 1:19-29
3. Breucking E, Reimnitz P, Schara U, Mortier W: Anesthetic complications. The incidence of severe anesthetic complications in patients and families with progressive muscular dystrophy of the Duchenne and Becker types. Anaesthesist 2000; 49:187-95
4. Költgen D, Franke C: The coexistence of embryonic and adult acetylcholine receptors in sarcolemma of mdx dystrophic mouse muscle: An effect of regeneration or muscular dystrophy? Neurosci Lett 1994; 173:79-82
5. Gattenlöhner S, Schneider C, Thamer C, Klein R, Roggendorf W, Gohlke F, Niethammer C, Czub S, Vincent A, Müller-Hermelink HK, Marx A: Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders. Brain 2002; 125:1309-19
6. Henderson WA: Succinylcholine-induced cardiac arrest in unsuspected Duchenne muscular dystrophy. Can Anaesth Soc J 1984; 31:444-6
7. Ririe DG, Shapiro F, Sethna NF: The response of patients with Duchenneǎ™s muscular dystrophy to neuromuscular blockade with vecuronium. ANESTHESIOLOGY 1998; 88:351-4
8. Schmidt J, Muenster T, Wick S, Forst J, Schmitt HJ: Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy. Br J Anaesth 2005; 95:769-72
9. Wick S, Muenster T, Schmidt J, Forst J, Schmitt HJ: Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy. ANESTHESIOLOGY 2005; 102:915-9
10. Viby-Mogensen J, Engbaek J, Eriksson LI, Gramstad L, Jensen E, Jensen FS, Koscielniak-Nielsen Z, Skovgaard LT, Ostergaard D: Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40:59-74
11. Østergaard D, Gätke MR, Berg H, Rasmussen SN, Viby-Mogensen J: The pharmacodynamics and pharmacokinetics of mivacurium in children. Acta Anaesthesiol Scand 2002; 46:512-8
12. Cook DR, Gronert BJ, Woelfel SK: Comparison of the neuromuscular effects of mivacurium and suxamethonium in infants and children. Acta Anaesthesiol Scand Suppl 1995; 106:35-40
13. Markakis DA, Lau M, Brown R, Luks AM, Sharma ML, Fisher DM: The pharmacokinetics and steady state pharmacodynamics of mivacurium in children. ANESTHESIOLOGY 1998; 88:978-83
14. McCluskey A, Meakin G: Dose-response and minimum time to satisfactory intubation conditions after mivacurium in children. Anaesthesia 1996; 51:438-41
15. Alifimoff JK, Goudsouzian NG: Continuous infusion of mivacurium in children. Br J Anaesth 1989; 63:520-4
16. Sarner JB, Brandom BW, Woelfel SK, Dong ML, Horn MC, Cook DR, McNulty BF, Foster VJ: Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia. Anesth Analg 1989; 68:116-21
17. Ihmsen H, Viethen V, Forst J, Schwilden H, Schmitt HJ, Muenster T: Pharmacodynamic modeling of rocuronium in adolescents with Duchenne muscular dystrophy. Eur J Anaesthesiol 2009; 26:105-10